Delving into the Latest Updates on GATT Technologies BV with Synapse

Overview

This is a pre-market, prospective, randomized (1:1), multicenter, pivotal clinical investigation. The purpose of this investigation is to determine the clinical performance of GATT-Patch as compared with SURGICEL® Original for the management of minimal, mild, or moderate bleeding during minimally invasive liver and gallbladder surgery.

Start Date06 Oct 2023

Sponsor / Collaborator

GATT Technologies BV

NCT05385952

/ CompletedNot Applicable

A Prospective, Multicenter, Randomized Clinical Investigation Evaluating the Safety and Efficacy of GATT-Patch Versus TachoSil for Hemostasis During Open Liver Surgery

This is a pre-market, prospective, randomized (2:1), multicenter, multi-national pivotal clinical investigation. The purpose of this investigation is to determine the clinical safety and performance of GATT-Patch as compared with TachoSil for the management of minimal, mild, or moderate bleeding during elective open liver surgery.

Start Date04 Aug 2022

Sponsor / Collaborator

GATT Technologies BV

[+1]

NL-OMON53880

/ SuspendedNot Applicable

A Prospective, Multicenter, Randomized Clinical Investigation Evaluating the Safety and Efficacy of GATT-Patch Versus TachoSil for Hemostasis During Open Liver Surgery - Safety/efficacy of GATT-Patch vs TachoSil During Open Liver Surgery

Start Date25 Jul 2022

Sponsor / Collaborator

GATT Technologies BV

100 Clinical Results associated with GATT Technologies BV

Login to view more data

0 Patents (Medical) associated with GATT Technologies BV

Login to view more data

1

Literatures (Medical) associated with GATT Technologies BV

Journal of Materials Chemistry BQ2 · ENGINEERING & TECHNOLOGY

Bone-adhesive barrier membranes based on alendronate-functionalized poly(2-oxazoline)s

Q2 · ENGINEERING & TECHNOLOGY

Article

Author: Bender, Johan C. M. E. ; Sánchez-Fernández, María J. ; Peerlings, Manon ; Félix Lanao, Rosa P. ; van Hest, Jan C. M. ; Leeuwenburgh, Sander C. G.

Novel bone-adhesive barrier membranes were successfully developed using a solvent-free approach by combining an occlusive polyester backing layer with a gelatin carrier impregnated with calcium-binding alendronate-functionalized poly(2-oxazoline)s.

100 Deals associated with GATT Technologies BV

Login to view more data

100 Translational Medicine associated with GATT Technologies BV

Login to view more data